captopril has been researched along with Low Bone Density in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Diao, TY; Gu, SS; Pan, H; Wong, MS; Zhang, FY; Zhang, Y | 1 |
Chen, F; Cui, L; Liu, YY; Wu, T; Xu, BL; Yao, WM | 1 |
2 other study(ies) available for captopril and Low Bone Density
Article | Year |
---|---|
Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.
Topics: Acid Phosphatase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Isoenzymes; Male; Mice; Mice, Inbred DBA; NF-kappa B; Osteocalcin; Osteoclasts; Random Allocation; Renin; Renin-Angiotensin System; RNA, Messenger; Streptozocin; Tartrate-Resistant Acid Phosphatase; Tibia; Transforming Growth Factor beta; Up-Regulation | 2014 |
Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts.
Topics: Alkaline Phosphatase; Animals; Biomechanical Phenomena; Bone Diseases, Metabolic; Captopril; Cells, Cultured; Female; Osteoblasts; Osteogenesis; Ovariectomy; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2011 |